首页|抗CD33单克隆抗体肽图分析方法的建立与验证

抗CD33单克隆抗体肽图分析方法的建立与验证

扫码查看
目的 建立抗CD33单克隆抗体肽图分析方法并对方法进行验证.方法 分别使用不同类型设备和不同流动相体系进行抗CD33抗体肽图检测.通过合成抗体CDR区域肽段进行特征肽段定位,并用质谱法对定位结果进行确认.以相对保留时间作为判断依据,根据《中国药典》2020年版完成方法验证.结果 超高效液相色谱法(ultraperformance liquid chromoto-graph,UPLC)进行肽图检测比高效液相色谱法(high performance liquid chromotograph,HPLC)时间更短,三氟乙酸流动相体系相比甲酸流动相体系分离度更高.使用合成肽段的定位结果与质谱鉴定结果一致.方法专属性验证结果显示制剂空白、样品溶液空白对肽图特征峰检测无干扰,不同抗体肽图谱之间存在明显差异;重复性验证结果显示6份平行样品间特征肽段相对保留时间相对标准偏差(RSD)为0.01%~0.05%;中间精密度验证结果显示不同分析人员特征肽段相对保留时间RSD为0.04%~0.32%;耐用性验证结果显示不同酶处理条件[胰蛋白酶量为(1±0.2)μg、酶解温度为(37±1)℃、酶解时间为(4±1)h]特征肽段相对保留时间RSD为0.02%~0.09%,不同色谱条件[三氟乙酸占比(0.08±0.02)%、流速(0.3±0.05)mL·min-1、柱温(40±2)℃]、不同批次色谱柱特征肽段相对保留时间RSD为0.36%~1.43%.样品溶液在25 h内检测,特征肽段相对保留时间RSD为0.01%~0.04%.结论 本研究采用合成肽段对液相肽图检测中的肽段进行定位,同时采用相对保留时间进行检测结果的判定,为生物药肽图检测提供了新的思路.
Development and Validation of A Method for Peptide Mapping of An Anti-CD33 Monoclonal Antibody
OBJECTIVE To develop and validate a peptide mapping method of an anti-CD33 monoclonal antibody.METHODS Different types of chromatographs(HPLC,UPLC)and different mobile phase systems(formic acid,trifluoroacetic acid)were used for peptide map detection of anti-CD33 antibody.The signature peptide segments were localized using synthetic CDR peptide of the antibody and the localization results were confirmed by mass spectrometry.Based on the relative retention time(RRT),the specificity,precision,and robustness of the method were validated according to the Pharmacopoeia of the People's Republic of China(ChP,2020).RESULTS The separation time of the peptides by UPLC was shorter than that by HPLC,and the degrees of separation with trifluoroacetic acid in the mobile phase were higher than that with formic acid.The identification results of the signature peptide seg-ment using the maps of synthetic peptide segments were consistent with the results of mass spectrometry.The specificity validation demon-strated that the formulation blank and sample solution blank did not interfere with the detection of signature peptide segments,and there were significant differences between peptide mapping results of different antibodies.The repeatability validation showed that the RSDs(RRT)of signature peptide segments between six parallel samples were 0.01%-0.05%;the intermediate precision validation proved that the RSDs(RRT)of signature peptide segments for different analysts were 0.04%-0.32%;the robustness validation exhibited that the RSDs(RRT)of signature peptide segments were 0.02%-0.09%under different enzyme treatment conditions and 0.36%-1.43%under different chromatographic conditions.Within 25 h in detection,the RSDs(RRT)of the signature peptide segments were 0.01%-0.04%.CONCLUSION This study uses synthetic peptide segments for peptide localization in peptide mapping detection and uses relative retention time to determine the results,which provide a new approach for biopharmaceutical peptide mapping detection.

peptide mappingUPLCtrifluoroacetic acidMS

白露、叶日平、刘蒙蒙、李雪琪、张秀真、赵永新

展开 >

杭州多禧生物科技有限公司,杭州 310018

肽图分析 超高效液相色谱法 三氟乙酸 质谱

2024

中国药学杂志
中国药学会

中国药学杂志

CSTPCD北大核心
影响因子:0.957
ISSN:1001-2494
年,卷(期):2024.59(16)